IRF7 promoted the polarization of tumor-associated macrophages (TAMs) to M2 type, inhibited anti-inflammatory factor production, enhanced immune escape of tumor cells, proliferation and migration of breast cancer cells, and thus promoting the development of breast cancer. This evidence concerns the gene IRF7 and breast cancer.